Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » News out today from Nutra Pharma about new OTC pain reliever (Page 1)

 - UBBFriend: Email this page to someone!   This topic comprises 2 pages: 1  2   
Author Topic: News out today from Nutra Pharma about new OTC pain reliever
biotechguy0331
Member


Rate Member
Icon 1 posted      Profile for biotechguy0331         Edit/Delete Post   Reply With Quote 
check out this company's 1-month chart -- Nutra Pharma (OTC:NPHC) -- this was out this morning:

Nutra Pharma Completes FDA Submission for Cobroxin - a Drug for the Treatment of Stage 2 (Moderate to Severe) Chronic Pain

http://www.nutrapharma.com/newsroom/display.php?newsid=134

Posts: 91 | Registered: Oct 2004  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
I like it. Thanks for Heads UP!

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
biotechguy0331
Member


Rate Member
Icon 1 posted      Profile for biotechguy0331         Edit/Delete Post   Reply With Quote 
more news out this morning for NPHC -- http://www.nutrapharma.com/newsroom/display.php?newsid=135
Posts: 91 | Registered: Oct 2004  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
Up 40% today; now at .31, ask .34.
"BEST NEW PRODUCT AWARD" - IMO, this stock should continue to increase as word gets out.

Nutra Pharma's Recently Launched Pain Reliever, Cobroxin, Wins "Best New Product" Award at Retailing Conference
Cobroxin, the First Clinically Proven Treatment for Stage 2 (Moderate to Severe) Chronic Pain, Was Selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference in Miami, Florida

Aug. 31, 2009 (U.S. Equity News) --

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.

"Winning this award is an exciting achievement for Nutra Pharma, as it reflects the significant amount of positive response we have received from retailers who are looking to offer their customers a safe and effective alternative to current pain relievers," commented Rik J. Deitsch, Chairman and CEO of Nutra Pharma. "As we begin introducing Cobroxin through retailers this fall, we plan to continue our efforts educating both retailers and consumers about Cobroxin's unique analgesic properties, which do not rely on opiates or acetaminophen for its pain relieving effects," he concluded.

Cobroxin is the first OTC pain reliever clinically proven to treat Stage 2 (moderate to severe) chronic pain. The drug, which was developed by Nutra Pharma's wholly-owned drug discovery subsidiary, ReceptoPharm, will be available as an oral spray (NDC47219-102-52) for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel (NDC47219-104-50) for treating repetitive stress, arthritis, and joint pain.

Additional benefits to Cobroxin include:

All Natural

Non-Addictive

Non-Narcotic

Non-Opiate

More Potent than Morphine

Long Lasting

Recently, Nutra Pharma announced a licensing agreement that grants XenaCare Holdings (OTCBB: XCHO) ongoing exclusive marketing and distribution rights for Cobroxin within the United States in return for meeting specific minimum performance requirements. In addition, the Company also announced successful submission of final Cobroxin packaging and labeling to the Food and Drug Administration (FDA), the final step required to begin selling Cobroxin.

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
this seems good
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
Up 14% again at .3775 at 10:50am

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
lots of play with this stock
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
I think if anyone is interested in this stock should sign up for their webcast on September 10th... that will probably answer all of our questions http://www.nutrapharma.com/****

probably have a jump to that day...

Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
.385 up 17%. Did anyone listen to webcast?

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
DEFINITE PLAY HERE!!! they have so much potential i believe the webcast is tonite!
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
PS UP 25% .409! GO BABY GO
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
With StocksHaven Investments in the house, they have so many connections. Of course its possible, anything they profile skyrockets
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
Online Presentation: Breakthrough Treatment Of Pain (OTC:NPHC)
Chairman and CEO, Rik J Deitsch Set to Conduct a Webinar Conference Call September 10, 9-10:30 pm EST (OTC:NPHC)

Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
Closed at .45; steadily rising.

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
How high do you think it will go?
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
moogoo gaipan
Member


Rate Member
Icon 1 posted      Profile for moogoo gaipan     Send New Private Message       Edit/Delete Post   Reply With Quote 
O/T: If you like Nutra Pharma, then you may want to check out CTIX, also. They're working on new non-toxic drugs that will treat drug resistant cancers and blood pressure conditions, etc.

Animal tests have been very positive. PPS for both both stock is about the same.

Posts: 143 | Registered: May 2008  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by moogoo gaipan:
O/T: If you like Nutra Pharma, then you may want to check out CTIX, also. They're working on new non-toxic drugs that will treat drug resistant cancers and blood pressure conditions, etc.

Animal tests have been very positive. PPS for both both stock is about the same.

Yes, news of this came out a couple weeks ago (8-25-09) and I think on Friday alone it finally moved up 60%.

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
we could see .50 by the end of the week!
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
How do u feel about XCHO? There pretty much directly linked to Nutra Pharma... seems like a good buy at .078 right now
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
a surfer
Member


Member Rated:
4
Icon 1 posted      Profile for a surfer     Send New Private Message       Edit/Delete Post   Reply With Quote 
broke .60
Posts: 6410 | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
BooDog
Member


Icon 1 posted      Profile for BooDog     Send New Private Message       Edit/Delete Post   Reply With Quote 
GOVX showing some potential

GEOVAX LABS INC(OTC BB: GOVX.OB)
Last Trade: 0.165
Trade Time: 1:52pm ET
Change: 0.025 (17.86%)
Prev Close: 0.14
Open: 0.131
Bid: 0.165 x 5000
Ask: 0.169 x 5000
1y Target Est: N/A
Day's Range: 0.128 - 0.20
52wk Range: N/A
Volume: 5,231,760
Avg Vol (3m): N/A
Market Cap: 124.55M
P/E (ttm): N/A
EPS (ttm): -0.005
Div

GeoVax Labs Requests pre-IND Meeting With FDA
Protocol Submitted for Phase 1 Therapeutic HIV/AIDS Vaccine Trial
Press Release
Source: GeoVax Labs, Inc.
On Monday September 21, 2009, 11:17 am EDT
Buzz up! 1 Print
Companies:Geovax Labs, Inc.
ATLANTA, Sept. 21 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX - News; the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.

Related Quotes
Symbol Price Change
GOVX.OB 0.17 +0.03


{"s" : "govx.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""} HIV affects the entire globe and comes in a variety of subtypes. Clade B is the predominant subtype in North America, where there are roughly 60,000 new infections each year. Globally, there are about 2.5 million AIDS infections per year, most primarily involving subtypes AG, B, and C. In 2007, UNAIDS reported 1.3 million people living with AIDS in North America and 33.2 million people living with AIDS worldwide.

"This pre-IND meeting with the FDA is a significant step toward meeting the needs of those individuals currently infected with HIV/AIDS. The FDA has 60 days from our submission to review our proposal and respond with questions or comments," stated Robert McNally, Ph.D., president and chief executive officer. "The need for a HIV/AIDS vaccine is clear, based on the continued increase of new infections in the United States, despite years of education and preventative measures. Current costs for oral medications and the numerous side effects of these drugs give further urgency to the need for a therapeutic vaccine," noted Dr. McNally.

A new IND with the FDA is required since this will be the first time the GeoVax vaccine will be used for a therapeutic application. The Phase 1 therapeutic protocol stresses safety parameters to minimize any risk to the volunteers. The protocol, conceived with collaboration from ARCA (AIDS Research Consortium of Atlanta), has specific objectives to optimize safety while evaluating the ability for the vaccine to elicit protective immune responses in vaccinated participants. The proposed trial is based on the achievement of excellent post vaccine viral control in animal trials conducted in recently infected non-human primates at the Yerkes National Primate Research Center, affiliated with Emory University. The proposed human trial follows the precedents set in the preclinical animal trials and is a critical step towards developing a therapeutic vaccine for HIV-1 infected humans.

Submission of a request to the FDA for a pre-IND meeting is the first step in a process that is expected to take a number of months to complete. Commencement of the trial is targeted for the first quarter of 2010.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person become infected. GeoVax AIDS vaccines also may be effective as a therapeutic treatment (for people already infected with the HIV-1 virus).

GeoVax's core AIDS vaccine technologies were developed by Dr. Harriet Robinson, Senior V.P. of Research and Development, through a collaboration of colleagues at Emory University's Vaccine Center, the National Institutes of Health (NIH), The Centers for Disease Control and Prevention (CDC) and GeoVax.

GeoVax's AIDS vaccines have moved forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN) based in Seattle, Washington. The HVTN, funded through a cooperative agreement with the National Institutes of Health (NIH), is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines. Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with a $17 million IPCAVD grant awarded in late 2007.

Safe Harbor Statement

All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.

--------------------
All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?

Posts: 7780 | From: Virginia | Registered: May 2006  |  IP: Logged | Report this post to a Moderator
Free Muney
Member


Rate Member
Icon 1 posted      Profile for Free Muney     Send New Private Message       Edit/Delete Post   Reply With Quote 
gangbusters! good find.

--------------------
Contrarian views always appreciated.... :p

Posts: 361 | From: Portland, Oregon | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
a surfer
Member


Member Rated:
4
Icon 1 posted      Profile for a surfer     Send New Private Message       Edit/Delete Post   Reply With Quote 
NPHC CLOSE AT .68

http://stockcharts.com/charts/gallery.html?NPHC

Posts: 6410 | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
this stock is very possible of a 2.00 3.00 if news keeps coming out...
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
BooDog
Member


Icon 1 posted      Profile for BooDog     Send New Private Message       Edit/Delete Post   Reply With Quote 
nice catch biotechguy0331. Congrats!

--------------------
All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?

Posts: 7780 | From: Virginia | Registered: May 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
Liftoff for Cobroxin is getting closer. The noise has already started building. Pain is the primary reason people go to doctors in this country. Wait until ABC news or Fox pick it up.
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
a surfer
Member


Member Rated:
4
Icon 1 posted      Profile for a surfer     Send New Private Message       Edit/Delete Post   Reply With Quote 
.93 close
Posts: 6410 | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
i believe this will continue to climb till october 8th!
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by Surferguy681:
i believe this will continue to climb till october 8th!

Oct 8th? Why you think till then?

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by Surferguy681:
this stock is very possible of a 2.00 3.00 if news keeps coming out...

So it will be this high by Oct. 8th?

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
I thought I read something about Product release expected on that day but I cant find it where I read that.. Could of just been speculation of release
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Hot-Pepper
Member


Member Rated:
4
Icon 1 posted      Profile for Hot-Pepper     Send New Private Message       Edit/Delete Post   Reply With Quote 
Goodmorning Oldseven & Surferguy681,

I read in the news over the weekend via CNN that there is a vaccine that has shown promise on the HIV . Is NPHC subsidiary the company testing this new vaccine ?

Posts: 602 | From: Minneapolis | Registered: Jul 2009  |  IP: Logged | Report this post to a Moderator
oldseven
Member


Rate Member
Icon 1 posted      Profile for oldseven     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by Hot-Pepper:
Goodmorning Oldseven & Surferguy681,

I read in the news over the weekend via CNN that there is a vaccine that has shown promise on the HIV . Is NPHC subsidiary the company testing this new vaccine ?

I do not believe so, I heard that also and I can't remember what the company was, but seems to me I looked it up and either it was a high priced stock or not traded, I will see if I can find it.

--------------------
Only ONE good stock away from retirement!

Posts: 493 | Registered: May 2009  |  IP: Logged | Report this post to a Moderator
Surferguy681
Member


Rate Member
Icon 1 posted      Profile for Surferguy681     Send New Private Message       Edit/Delete Post   Reply With Quote 
Awww Man XCHO Had I big jump I knew I shoulda Jumped in earlier!!!
Posts: 43 | From: Orlando | Registered: Jun 2006  |  IP: Logged | Report this post to a Moderator
Hot-Pepper
Member


Member Rated:
4
Icon 1 posted      Profile for Hot-Pepper     Send New Private Message       Edit/Delete Post   Reply With Quote 
Thank you Oldseven
Posts: 602 | From: Minneapolis | Registered: Jul 2009  |  IP: Logged | Report this post to a Moderator
  This topic comprises 2 pages: 1  2   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2019 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share